Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Caplin Point Laboratories Revenue

In the fiscal year ending March 31, 2026, Caplin Point Laboratories had annual revenue of 21.87B INR with 12.77% growth. Caplin Point Laboratories had revenue of 6.00B in the quarter ending March 31, 2026, with 18.95% growth.

• Revenue: 21.87B
• Revenue Growth: +12.77%
• P/S Ratio: 7.33
• Revenue / Employee: 5.51M
• Employees: 3,966
• Market Cap: 160.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	21.87B	2.48B	12.77%
Mar 31, 2025	19.40B	2.43B	14.35%
Mar 31, 2024	16.96B	2.28B	15.51%
Mar 31, 2023	14.68B	1.97B	15.53%
Mar 31, 2022	12.71B	2.09B	19.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error